NM_000075.4(CDK4):c.355-7A>C AND Melanoma, cutaneous malignant, susceptibility to, 3

Germline classification:: Likely benign (1 submission)
Last evaluated:: Sep 25, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004790633.1

Allele description [Variation Report for NM_000075.4(CDK4):c.355-7A>C]

NM_000075.4(CDK4):c.355-7A>C

Gene:

CDK4:cyclin dependent kinase 4 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12q14.1

Genomic location:

Preferred name:

NM_000075.4(CDK4):c.355-7A>C

HGVS:

NC_000012.12:g.57751097T>G
NG_007484.2:g.6285A>C
NM_000075.4:c.355-7A>CMANE SELECT
LRG_490:g.6285A>C
NC_000012.11:g.58144880T>G

Molecular consequence:

NM_000075.4:c.355-7A>C - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Melanoma, cutaneous malignant, susceptibility to, 3
Synonyms:: Cutaneous malignant melanoma 3
Identifiers:: MONDO: MONDO:0012183; MedGen: C1836892; Orphanet: 618; OMIM: 609048

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV005407737	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Likely benign (Sep 25, 2024)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV005407737

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Likely benign
(Sep 25, 2024)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV005407737.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 30, 2024

ClinVar

Relating variation to medicine